• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量磁共振成像生物标志物在骨髓纤维化模型鼠胫骨骨髓中的可重复性。

Repeatability of Quantitative Magnetic Resonance Imaging Biomarkers in the Tibia Bone Marrow of a Murine Myelofibrosis Model.

机构信息

Department of Radiology and the Center for Molecular Imaging, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA.

Department of Biological Chemistry, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA.

出版信息

Tomography. 2023 Feb 28;9(2):552-566. doi: 10.3390/tomography9020045.

DOI:10.3390/tomography9020045
PMID:36961004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10037563/
Abstract

Quantitative MRI biomarkers are sought to replace painful and invasive sequential bone-marrow biopsies routinely used for myelofibrosis (MF) cancer monitoring and treatment assessment. Repeatability of MRI-based quantitative imaging biomarker (QIB) measurements was investigated for apparent diffusion coefficient (ADC), proton density fat fraction (PDFF), and magnetization transfer ratio (MTR) in a JAK2 V617F hematopoietic transplant model of MF. Repeatability coefficients (RCs) were determined for three defined tibia bone-marrow sections (2-9 mm; 10-12 mm; and 12.5-13.5 mm from the knee joint) across 15 diseased mice from 20-37 test-retest pairs. Scans were performed on consecutive days every two weeks for a period of 10 weeks starting 3-4 weeks after transplant. The mean RC with (95% confidence interval (CI)) for these sections, respectively, were for ADC: 0.037 (0.031, 0.050), 0.087 (0.069, 0.116), and 0.030 (0.022, 0.044) μm/ms; for PDFF: 1.6 (1.3, 2.0), 15.5 (12.5, 20.2), and 25.5 (12.0, 33.0)%; and for MTR: 0.16 (0.14, 0.19), 0.11 (0.09, 0.15), and 0.09 (0.08, 0.15). Change-trend analysis of these QIBs identified a dynamic section within the mid-tibial bone marrow in which confident changes (exceeding RC) could be observed after a four-week interval between scans across all measured MRI-based QIBs. Our results demonstrate the capability to derive quantitative imaging metrics from mouse tibia bone marrow for monitoring significant longitudinal MF changes.

摘要

定量 MRI 生物标志物被寻求替代常规用于骨髓纤维化 (MF) 癌症监测和治疗评估的疼痛和侵入性连续骨髓活检。在 JAK2 V617F 造血移植 MF 模型中,研究了基于 MRI 的定量成像生物标志物 (QIB) 测量的表观扩散系数 (ADC)、质子密度脂肪分数 (PDFF) 和磁化传递比 (MTR) 的重复性。在 15 只患病小鼠的 20-37 对测试-复测对中,确定了三个定义的胫骨骨髓节段(距膝关节 2-9mm;10-12mm;和 12.5-13.5mm)的重复性系数 (RC)。在移植后 3-4 周开始的 10 周内,每隔两周连续两天进行扫描。这些节段的平均 RC(95%置信区间 (CI))分别为:ADC:0.037(0.031,0.050)、0.087(0.069,0.116)和 0.030(0.022,0.044)μm/ms;PDFF:1.6(1.3,2.0)、15.5(12.5,20.2)和 25.5(12.0,33.0)%;MTR:0.16(0.14,0.19)、0.11(0.09,0.15)和 0.09(0.08,0.15)。这些 QIB 的变化趋势分析确定了一个在中胫骨骨髓中的动态节段,在所有测量的基于 MRI 的 QIB 中,在两次扫描之间间隔四周后,可以观察到有信心的变化(超过 RC)。我们的结果表明,能够从小鼠胫骨骨髓中获得定量成像指标,用于监测显著的纵向 MF 变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/10037563/1add382a99c2/tomography-09-00045-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/10037563/a6c57908aed3/tomography-09-00045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/10037563/f3904562129a/tomography-09-00045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/10037563/93c13bd37a9a/tomography-09-00045-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/10037563/1add382a99c2/tomography-09-00045-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/10037563/a6c57908aed3/tomography-09-00045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/10037563/f3904562129a/tomography-09-00045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/10037563/93c13bd37a9a/tomography-09-00045-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/10037563/1add382a99c2/tomography-09-00045-g004.jpg

相似文献

1
Repeatability of Quantitative Magnetic Resonance Imaging Biomarkers in the Tibia Bone Marrow of a Murine Myelofibrosis Model.定量磁共振成像生物标志物在骨髓纤维化模型鼠胫骨骨髓中的可重复性。
Tomography. 2023 Feb 28;9(2):552-566. doi: 10.3390/tomography9020045.
2
Improved Repeatability of Mouse Tibia Volume Segmentation in Murine Myelofibrosis Model Using Deep Learning.深度学习提高小鼠骨髓纤维化模型胫骨体积分割的可重复性。
Tomography. 2023 Mar 7;9(2):589-602. doi: 10.3390/tomography9020048.
3
Histographic analysis of oedema and fat in inflamed bone marrow based on quantitative MRI.基于定量 MRI 的骨髓炎水肿和脂肪的组织学分析。
Eur Radiol. 2020 Sep;30(9):5099-5109. doi: 10.1007/s00330-020-06785-x. Epub 2020 Apr 14.
4
Proton density fat fraction MRI of vertebral bone marrow: Accuracy, repeatability, and reproducibility among readers, field strengths, and imaging platforms.磁共振质子密度脂肪分数成像技术在椎体骨髓中的应用:读者间、场强间和成像平台间的准确性、可重复性和可再现性。
J Magn Reson Imaging. 2019 Dec;50(6):1762-1772. doi: 10.1002/jmri.26748. Epub 2019 Apr 13.
5
Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study.在不同场强和扫描间隔下质子密度脂肪分数测量的准确性和精密度:一项体模和人体研究。
J Magn Reson Imaging. 2019 Jul;50(1):305-314. doi: 10.1002/jmri.26575. Epub 2018 Nov 14.
6
Quantitative MRI reveals heterogeneous impacts of treatment on diseased bone marrow in a mouse model of myelofibrosis.定量 MRI 揭示了治疗对骨髓纤维化小鼠模型中病变骨髓的异质性影响。
Magn Reson Med. 2024 Jun;91(6):2568-2578. doi: 10.1002/mrm.30016. Epub 2024 Jan 24.
7
Diagnostic Accuracy of Quantitative Imaging Biomarkers in the Differentiation of Benign and Malignant Vertebral Lesions : Combination of Diffusion-Weighted and Proton Density Fat Fraction Spine MRI.定量影像学标志物在鉴别良恶性脊柱病变中的诊断准确性:弥散加权和质子密度脂肪分数脊柱 MRI 的联合应用。
Clin Neuroradiol. 2021 Dec;31(4):1059-1070. doi: 10.1007/s00062-021-01009-1. Epub 2021 Mar 31.
8
Comparison of proton density fat fraction, simultaneous R2*, and apparent diffusion coefficient for assessment of focal vertebral bone marrow lesions.质子密度脂肪分数、同时 R2*和表观扩散系数在评估局灶性椎体骨髓病变中的比较。
Clin Radiol. 2020 Feb;75(2):123-130. doi: 10.1016/j.crad.2019.09.141. Epub 2019 Oct 31.
9
Associations of incidental vertebral fractures and longitudinal changes of MR-based proton density fat fraction and T2* measurements of vertebral bone marrow.偶然发现的椎体骨折与基于磁共振质子密度脂肪分数和椎体骨髓 T2*测量的纵向变化的相关性。
Front Endocrinol (Lausanne). 2022 Nov 17;13:1046547. doi: 10.3389/fendo.2022.1046547. eCollection 2022.
10
A Pilot Study of Quantitative MRI Parametric Response Mapping of Bone Marrow Fat for Treatment Assessment in Myelofibrosis.一项关于骨髓脂肪定量MRI参数反应映射用于骨髓纤维化治疗评估的初步研究。
Tomography. 2016 Mar;2(1):67-78. doi: 10.18383/j.tom.2016.00115.

引用本文的文献

1
The National Cancer Institute's Co-Clinical Quantitative Imaging Research Resources for Precision Medicine in Preclinical and Clinical Settings.国家癌症研究所的合作临床定量成像研究资源,用于临床前和临床环境中的精准医学。
Tomography. 2023 Apr 30;9(3):931-941. doi: 10.3390/tomography9030076.

本文引用的文献

1
Myelofibrosis.骨髓纤维化。
Blood. 2023 Apr 20;141(16):1954-1970. doi: 10.1182/blood.2022017423.
2
Multiparametric MRI to quantify disease and treatment response in mice with myeloproliferative neoplasms.多参数 MRI 定量检测骨髓增殖性肿瘤小鼠的疾病和治疗反应。
JCI Insight. 2022 Oct 10;7(19):e161457. doi: 10.1172/jci.insight.161457.
3
A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy.一种用于骨髓纤维化治疗的淋巴吸收多靶点激酶抑制剂。
Nat Commun. 2022 Aug 17;13(1):4730. doi: 10.1038/s41467-022-32486-8.
4
Test-retest repeatability and interobserver variation of healthy tissue metabolism using 18F-FDG PET/CT of the thorax among lung cancer patients.肺癌患者 18F-FDG PET/CT 胸部检查中健康组织代谢的复测重复性和观察者间变异性。
Nucl Med Commun. 2022 May 1;43(5):549-559. doi: 10.1097/MNM.0000000000001537.
5
State-of-the-Art Review on Myelofibrosis Therapies.骨髓纤维化治疗的最新进展综述
Clin Lymphoma Myeloma Leuk. 2022 May;22(5):e350-e362. doi: 10.1016/j.clml.2021.11.007. Epub 2021 Nov 15.
6
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis.异质性骨髓基质祖细胞通过可用药理性警报素轴驱动骨髓纤维化。
Cell Stem Cell. 2021 Apr 1;28(4):637-652.e8. doi: 10.1016/j.stem.2020.11.004. Epub 2020 Dec 9.
7
Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management.原发性骨髓纤维化:诊断、危险分层和治疗的 2021 年更新。
Am J Hematol. 2021 Jan;96(1):145-162. doi: 10.1002/ajh.26050. Epub 2020 Dec 2.
8
Across Aging and Aplasia: A Digital Pathology Workflow for Quantification of Bone Marrow Compartments in Histological Sections.跨越衰老和发育不全:一种用于在组织切片中定量骨髓隔室的数字病理学工作流程。
Front Endocrinol (Lausanne). 2020 Sep 24;11:480. doi: 10.3389/fendo.2020.00480. eCollection 2020.
9
Co-Clinical Imaging Resource Program (CIRP): Bridging the Translational Divide to Advance Precision Medicine.联合临床影像资源计划(CIRP):弥合转化鸿沟,推进精准医学。
Tomography. 2020 Sep;6(3):273-287. doi: 10.18383/j.tom.2020.00023.
10
A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management.原发性骨髓纤维化:病理生理学、诊断和治疗的临床医生指南。
Blood Rev. 2021 Jan;45:100691. doi: 10.1016/j.blre.2020.100691. Epub 2020 Apr 7.